睿昂基因(688217.SH)上半年净利润355.43万元，同比下滑61.46%

Group 1 - The core viewpoint of the article is that Ruian Gene (688217.SH) reported a significant decline in both revenue and net profit for the first half of 2025, indicating potential challenges for the company [1] Group 2 - The company achieved operating revenue of 105 million yuan in the first half of 2025, representing a year-on-year decrease of 22.29% [1] - The net profit attributable to the parent company was 3.55 million yuan, down 61.46% compared to the same period last year [1] - The non-recurring net profit attributable to the parent company was -2.83 million yuan, contrasting with 5.14 million yuan in the same period last year [1]